The Indian government presented a budget focused on accelerating economic growth through significant public capital expenditure, targeting 12.2 lakh crores for FY 2026-27.
Major strategic initiatives were announced to boost domestic manufacturing in high-tech sectors, including the 'BioPharma Shakti' initiative (10,000 crores) and 'India's Semiconductor Mission 2.0'.
The budget outlines a clear path of fiscal consolidation, aiming to reduce the fiscal deficit to 4.3% of GDP and the debt-to-GDP ratio to 55.6%, signaling a commitment to macroeconomic stability.
Significant tax reforms are proposed, including a new Income Tax Act 2025, a reduction in the Minimum Alternate Tax (MAT) rate, and incentives for cloud services and courier exports to improve the business environment.
12 quotes
Concerns Raised
Execution risk associated with large-scale infrastructure and manufacturing projects.
Dependence on a volatile global environment, including impaired trade and disrupted supply chains.
Potential for inflationary pressures despite the focus on fiscal discipline.
Opportunities Identified
Establishing India as a global hub for biopharma and semiconductor manufacturing.
Unlocking significant growth in the SME sector through dedicated government funding.
Boosting exports and e-commerce through simplified customs processes and removal of value caps.
Attracting long-term foreign investment due to a stable macroeconomic outlook and pro-business reforms.